Altera confidentially filed for a U.S. initial public offering on September 15, putting another semiconductor company into the listings pipeline and potentially giving Intel shareholders a public valuation benchmark for a business in which Intel still owns 49%.
The San Jose-based chipmaker said its parent company confidentially submitted a draft Form S-1 to the Securities and Exchange Commission. Altera did not disclose how many shares it plans to sell, a price range or a valuation, and there is still no public prospectus. The company said the offering remains subject to SEC review, market conditions and other factors.
Reuters reported before the filing, citing people familiar with the matter, that the offering could raise more than $2 billion and could happen as early as this year. Reuters said a transaction of that size would rank among the larger semiconductor listings since Arm and Cerebras, but that comparison is Reuters’ framing rather than a claim by Altera.
What Altera Filed and What It Actually Makes
Altera is best known for field-programmable gate arrays, or FPGAs, chips that can be reconfigured after manufacturing for specialized workloads.
Its products are used across data centers, telecommunications networks, industrial equipment, aerospace and defense systems and AI applications. Altera is not a pure AI accelerator company in the Nvidia or Cerebras mold, but it markets FPGAs as complementary to GPUs for networking, data processing and some AI inference workloads inside data centers.
That AI exposure is likely to matter when the full S-1 becomes public. Lukas Muehlbauer, a research associate at IPOX, told Reuters that whether hyperscalers remain a material part of Altera’s customer base will be an important question for investors once the filing is available.
Until then, investors do not have public IPO financial statements to assess. Any revenue, margin or customer figures attributed to the forthcoming offering should therefore wait for the public prospectus rather than be inferred from the confidential filing.
Silver Lake Owns Control, While Intel Still Has 49%
Altera’s ownership structure dates to Intel’s decision to separate the business it had bought for roughly $16.7 billion in 2015.
Silver Lake agreed in April 2025 to acquire 51% of Altera in a transaction valuing the company at $8.75 billion. The deal closed that September, leaving Intel with a 49% minority stake and turning Altera back into a standalone company.
Abu Dhabi-backed AI investment firm MGX subsequently joined Silver Lake’s buyout group. MGX did not disclose the size of its investment. Reuters reported at the time that Intel remained the holder of the other 49%.
That means the IPO is relevant to Intel even if Intel does not sell shares in the offering. The eventual IPO valuation would give the market a quoted reference point for a large asset that Intel currently carries without a public market price.
Intel Carries Its Altera Investment at $3.2 Billion
Intel’s latest quarterly filing provides the most useful baseline.
As of June 27, 2026, Intel carried its non-marketable equity investment in Altera at $3.2 billion. Intel accounts for the holding using the equity method after deconsolidating Altera when control passed to Silver Lake. The carrying value was unchanged from the end of 2025.
For comparison, the $8.75 billion valuation attached to the 2025 Silver Lake transaction would put 49% of Altera at about $4.29 billion on a simple ownership basis. That is not a current valuation for Intel’s stake, and it should not be confused with Intel’s $3.2 billion accounting carrying value.
The reported $2 billion-plus IPO size cannot solve that valuation question by itself. A company can raise $2 billion at very different valuations depending on how much of its equity is sold, and Altera has not disclosed either the share count or price range.
What the IPO can eventually provide is a market price. Once terms are published, Intel investors will be able to compare the implied value of its remaining ownership with the $3.2 billion currently carried on Intel’s balance sheet. Whether Intel’s accounting treatment changes will depend on its ownership and influence after the transaction rather than simply on Altera becoming publicly traded.
Arm Raised About $5 Billion, While Cerebras Raised $5.55 Billion
The recent semiconductor comparison set shows why a $2 billion-plus deal would still be meaningful.
Arm raised $4.87 billion, commonly rounded to about $5 billion, when SoftBank sold 95.5 million shares in its 2023 U.S. IPO. The deal valued Arm at $54.5 billion on a fully diluted basis.
Cerebras then raised $5.55 billion in May 2026 after pricing 30 million shares at $185 each, giving the AI chipmaker a fully diluted valuation of roughly $56.4 billion.
Reuters used those two offerings as reference points when describing Altera’s proposed deal, while also noting that South Korea’s SK Hynix raised more than $26 billion from its U.S. listing in July.
The IPO Window Is Open, but It Is Selective
Altera’s filing also lands in a noticeably uneven listings market.
OpenAI CEO Sam Altman ruled out a 2026 IPO earlier this month, while Anthropic is reportedly pursuing the opposite path, with Nasdaq and an October listing discussed in recent reports. FinanceFeeds covered that divergence in OpenAI Ruled Out 2026. Anthropic Reportedly Picks Nasdaq for October as It Projects a Second Adjusted Profit.
Crypto investment platform Bitpanda has also delayed its planned Frankfurt IPO, saying market conditions are not yet right, after previously targeting a listing in the first half of 2026. FinanceFeeds reported this week that the process remains paused without a new timetable.
The contrast is not evidence that every semiconductor issuer can list while consumer technology cannot. Anthropic itself is an obvious counterexample. But it does show a selective market in which AI infrastructure and semiconductor companies are still testing public demand even as other high-profile issuers defer or reassess their plans.
For Intel shareholders, Altera’s filing adds another dimension. The offering is not just another semiconductor IPO candidate; it could finally attach a visible public-market price to a 49% holding that Intel currently reports as a $3.2 billion non-marketable investment.